| abstract |
An antagonistic anti-CGRP antibody for use as a medicine for the prevention and / or treatment of pain from chronic cancer, where pain from chronic cancer is due to one or more of the following conditions: adenocarcinoma in glandular tissue, blastoma in tissue embryonic organ, carcinoma in epithelial tissue, leukemia in tissues that form blood cells, lymphoma in lymphatic tissue, myeloma in bone marrow, sarcoma in connective or supporting tissue, adrenal cancer, AIDS-related lymphoma, bladder cancer, bone cancer , breast cancer, carcinoid tumors, cervical cancer, colon cancer, endometrial cancer, esophageal cancer, gastric cancer, neck cancer, hepatobiliary cancer, kidney cancer, leukemia, liver cancer, lung cancer, lymphoma (Hodgkin's disease), lymphoma (not Hodgkin's), oral cancer, ovarian cancer, pancreatic cancer, prostate cancer, rectal cancer, skin cancer, cancer Stomach cancer, testicular cancer, thyroid cancer, urethral cancer, bone tissue cancer, blood-producing cell cancer, bone marrow cancer, multiple myeloma, primary or secondary bone cancer, tumors that metastasize to bone, and tumors that infiltrate the nerve and the hollow viscus. |